Progressive muscular atrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:454706G12.2
Who is this for?
Show terms as
24Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Progressive muscular atrophy (PMA) is a rare motor neuron disease that primarily affects the lower motor neurons — the nerve cells in the spinal cord that control your muscles. It is sometimes considered a variant or subtype of amyotrophic lateral sclerosis (ALS), though it has distinct features. In PMA, the lower motor neurons gradually break down and die, which means the muscles they control become weak and shrink over time, a process called muscle atrophy. The disease usually begins in adulthood and tends to start in the hands, arms, or legs. Early symptoms often include muscle weakness, twitching (called fasciculations), and muscle wasting, particularly in the limbs. Unlike classic ALS, PMA does not typically show prominent signs of upper motor neuron damage early on, such as stiffness or exaggerated reflexes, though some patients may develop these signs later. The disease is progressive, meaning symptoms worsen over time. There is currently no cure for progressive muscular atrophy. Treatment focuses on managing symptoms, maintaining function, and improving quality of life. Physical therapy, occupational therapy, and assistive devices can help people stay as independent as possible. Some doctors may prescribe riluzole, a medication approved for ALS, though its benefit in PMA specifically is not firmly established. Research is ongoing to better understand PMA and develop more effective treatments.

Also known as:

Key symptoms:

Muscle weakness, especially in the arms and legsMuscle wasting or shrinking (atrophy)Muscle twitching (fasciculations)Muscle crampsDifficulty with fine hand movements like buttoning clothesWeakness in the feet leading to tripping or foot dropLoss of reflexesDifficulty lifting objectsTrouble walking or climbing stairsFatigueDifficulty swallowing in later stagesBreathing difficulties in advanced stagesWeight loss due to muscle loss

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Oct 2024Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

TrialRECRUITING
Dec 2023Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients

The University of Hong Kong — NA

TrialRECRUITING
Mar 2023Reducing Falls With Progressive Resistance Training for the Oldest Old Adults With Sarcopenia

Norwegian University of Science and Technology — NA

TrialACTIVE NOT RECRUITING
Sep 2022AngelMed Guardian® System PMA Post Approval Study

Angel Medical Systems

TrialRECRUITING
Jan 2019Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease

University of Maryland, Baltimore — NA

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Progressive muscular atrophy.

View clinical trials →

No actively recruiting trials found for Progressive muscular atrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Progressive muscular atrophy community →

Specialists

24 foundView all specialists →
CP
Cristina M Dias, PT - PhD
Specialist
PI on 1 active trial
UD
Umbertina Reed, Doctor
Specialist
PI on 1 active trial
LM
Laurent Servais, MD
Specialist
PI on 6 active trials1 Progressive muscular atrophy publication
MM
Michio Hirano, MD
NEW YORK, NY
Specialist
PI on 10 active trials
RP
Richard S Bedlack, MD, PhD
DURHAM, NC
Specialist
PI on 2 active trials
TP
Tamara Dangouloff, PhD
Specialist
PI on 1 active trial
JE
Jacqueline Montes, Pt, EdD
New York, New York
Specialist

Rare Disease Specialist

PI on 5 active trials
LP
Laurent Servais, MD, PhD
Liège
Specialist

Rare Disease Specialist

PI on 2 active trials
PM
Petra Kaufmann, MD
NEW YORK, NY
Specialist
PI on 2 active trials
JM
Jeffrey Statland, MD
KANSAS CITY, KS
Specialist
PI on 7 active trials
CM
Caroline Hugeron, MD
Specialist
PI on 1 active trial
TM
Thomas O. Crawford, MD
Specialist
PI on 1 active trial
PP
Prof Chiara Marini-Bettolo, MD, PhD
Specialist
PI on 1 active trial
DW
Dr Ching H. Wang
Specialist
PI on 2 active trials528 Progressive muscular atrophy publications
AM
Aga Lewelt, MD
ORLANDO, FL
Specialist
PI on 1 active trial1 Progressive muscular atrophy publication
TM
Thomas Crawford, MD
Specialist
PI on 2 active trials
RM
Richard Finkel, MD
Specialist
PI on 3 active trials
LP
Linette M. Kofod, Phys.Ther
Specialist
PI on 1 active trial
CW
Chris Winkelman
CLEVELAND, OH
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Progressive muscular atrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Progressive muscular atrophyForum →

No community posts yet. Be the first to share your experience with Progressive muscular atrophy.

Start the conversation →

Latest news about Progressive muscular atrophy

Disease timeline:

New recruiting trial: Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis

A new clinical trial is recruiting patients for Progressive muscular atrophy

New recruiting trial: AngelMed Guardian® System PMA Post Approval Study

A new clinical trial is recruiting patients for Progressive muscular atrophy

New recruiting trial: Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients

A new clinical trial is recruiting patients for Progressive muscular atrophy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my condition definitely PMA, or could it be ALS or another motor neuron disease?,What tests were done to rule out other conditions, and should genetic testing be considered?,How quickly is my disease likely to progress, and what signs should I watch for?,Would riluzole or any other medication be helpful in my case?,What therapies (physical, occupational, speech) should I start now?,Are there any clinical trials I might be eligible for?,When should I consider assistive devices or breathing support?

Common questions about Progressive muscular atrophy

What is Progressive muscular atrophy?

Progressive muscular atrophy (PMA) is a rare motor neuron disease that primarily affects the lower motor neurons — the nerve cells in the spinal cord that control your muscles. It is sometimes considered a variant or subtype of amyotrophic lateral sclerosis (ALS), though it has distinct features. In PMA, the lower motor neurons gradually break down and die, which means the muscles they control become weak and shrink over time, a process called muscle atrophy. The disease usually begins in adulthood and tends to start in the hands, arms, or legs. Early symptoms often include muscle weakness, t

How is Progressive muscular atrophy inherited?

Progressive muscular atrophy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Progressive muscular atrophy typically begin?

Typical onset of Progressive muscular atrophy is adult. Age of onset can vary across affected individuals.

Which specialists treat Progressive muscular atrophy?

24 specialists and care centers treating Progressive muscular atrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.